FRI0212 USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPY
Galina Tarasova(Association of Rheumatologists of Russia), Т. В. Попкова(Association of Rheumatologists of Russia), Е. А. Асеева(Association of Rheumatologists of Russia), M. Cherkasova(Association of Rheumatologists of Russia), Т. М. Reshetnyak(Russian Medical Academy of Continuous Professional Education), Д. В. Буханова(Association of Rheumatologists of Russia), S. К. Solovyev(Association of Rheumatologists of Russia), Б. С. Белов(Unknown)
Cited by 7
Related Papers
RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES
|Rheumatology Science and Practice|2018|151
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
|Rheumatology Science and Practice|2021|54
COVID-19: the new challenge for rheumatologists
|Modern Rheumatology Journal|2020|30
Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)
|Meditsinskiy sovet = Medical Council|2019|14
Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review
|Rheumatology Science and Practice|2021|14